SAVE THE DATE – 26 Jan 2017 – Taking life science to the stock market

26
jan
AstraZeneca Gothenburg
3 pm - 6 pm

Join us and your life science colleagues for an open, engaging and informative discussion around the best ways for small life science companies to raise capital to generate big value. This is part one of a two-part collaboration hosted by Nasdaq, AstraZeneca BioVentureHub and Sahlgrenska Science Park. Part two will take place at Sahlgrenska Science Park later in the spring 2017.

Presenters / panelists

  • Carl Bennet (Carl Bennet AB)
  • Adam Kostyal (Nasdaq)
  • Erik Gatenholm (Cellink)
  • Homan Panahi (Vator Securities)
  • Johannes Hulthe (Antaros Medical)
  • Charlotta Gummeson (Sahlgrenska Science Park)
  • Klementina Österberg (GU Ventures)
  • Magnus Björsne (AstraZeneca BioVentureHub)

More information and a registration page will be made available soon. To pre-register or to find out more, please send an email to bioventurehub@astrazeneca.com